As investors and traders we can easily take money and put it into a whole host of stocks which we think might 'bag or multi-bag' - just to make money - even though we don't really know or genuinely care for those companies or products.
Many of us here now have been holding because there is a genuine team at @PrimerdesignLtd & @MicrogenBioProd and they are worth following and investing in.
If your relatives were vulnerable in a care home..
Do you trust visitors tested by PrimerDesign or by something else?
It's Saturday, but the news is grim. The virus doesn't get a weekend off. It's spreading fast and killing and decisions are about to get made.
Ones that depend on diagnostics catching cases and stopping the infection reaching the most vulnerable.
Novacyt is the ethical choice.
What people who aren't fully clued in about, when discussing these different diagnostics companies, is that some like Novacyt undergo separate, months long, large scale evaluations on their products eg: qmul.ac.uk/media/news/202…
And they also help evaluate other products, without Any commercial interest, eg. Optigene and saliva a few months ago.
Denegrating all diagnostics companies, especially claiming they have 'no data' is woefully ignorant.
There are a lot of dodgy tests now...
But PrimerDesign is the most transparent.
And they run weekly sequencing, published here on Twitter too, for all to see.
I hope those onlooking at these companies take a little time to research individually before generalising or making knee-jerk reactions.
Some companies are doing the hard work and saving lives.
Critique is always needed, but it needs to be rational and proportionate, and blanket statements do not help any side.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
#NCYT has been installing Q16s and Q32s weekly now in the NHS, so what they've done with the care home trial is expand it now to include the NHS hospitals.
Also sent Tweet over to @JolyonMaugham as he's been very active on chasing up dodgy test firms who're selling UK Gov test kits with no independent assessments.
Please see study on Viasure's covid test in pic. It is shockingly bad. But they're still trying to sell it to NHS and even trying to push out a multiplex now too. They won't show ANY assessment of it. Just say it's 'CE marked'
If investors don't understand what that means, it means that Novacyt will eventually re-rate come 2021, and it will have a market capitalisation of 1 to 2 billion and keep growing.
To miss something so obvious, you will never have any credibility
Take a look at diagnostics companies, their revenues, and their market caps: